Important Change Regarding Hospital Requested Blood Test Appointments Prescribing of Wegovy to Patients with a History of Stroke/TIA Secondary Care Blood Tests Regarding the Meningococcal Outbreak in South East England Burkholderia stabilis associated with non-sterile wipes Switchboard LGBTQIA+ Support Line New screening videos to make health information more accessible for people with learning disabilities MMRV Vaccinations Smear Test Drop-In Morning New British Sign Language (BSL) signed content on GOV.UK NHS Breast and NHS Cervical Screening Programmes HOPE Programme – Chronic Pain, Fatigue, Anxiety & Depression YDAS – Torbay Young Person’s Drug and Alcohol Service New dates added for TALKWORKS’ menopause course Asthma “September Surge” Vaccinations at School ⚠️Results Line Changes ⚠️ Mounjaro Prescribing in Devon Primary Care🚫 HOPE Course for Chronic Pain & Fatigue Peninsula Cancer Care Survey Carers Forum – Tuesday 13th May 2025 South West Bowel Cancer Screening Measuring Loneliness (INTERACT) Study Torbay Vaccine Service HOPE Programme for Low Level Anxiety and Depression STARFISH: Steroid Administration Routes For Idiopathic Sudden Sensorineural Hearing Loss IMPACT-1 Study for People Suffering with PTSD HOPE Programme Anxiety and Depression When can I get my Flu Vaccine? RSV Vaccination for Pregnant Women RSV Vaccine for Older Adults Children and Family Health Devon (CFHD) Silvercloud online mental wellbeing programmes Still Experiencing Pain After Knee Cartilage Operation? – METEOR2 Study TRI Drug and Alcohol Service Survey for Men Experiencing Grief and Loss Maternity Hotline Other options when we run out of routine GP appointments Veteran Friendly GP Practice Long Covid Awareness How to Submit a Medical Request Using Patient Triage Behind the Scenes of your General Practice Heat Health Advice Patient advice and messages for elective care waiting lists Hayfever treatment starts at home Torbay General Practice Parkrun Measles cases prompt MMR vaccine call Travelling Abroad
IMPACT-1 Study for People Suffering with PTSD
The IMPACT-1 Study is clinical trial exploring the effect of an investigational, psychoactive oral medication for PTSD symptoms. People who have experienced a traumatic event and are now suffering symptoms of post-traumatic stress disorder (PTSD) can participate. The study is actively enrolling new participants and it is being conducted at select locations in the US, UK and Ireland. Click here to view a list of current study locations.
If you qualify for the IMPACT-1 Study, you can expect:
- Evaluations of your PTSD symptoms and overall health from a local physician.
- Study-related care at no cost and the potential to receive investigational oral medication.
- Compensation for travel expenses.
- The opportunity to help advance PTSD research, which may benefit other people with PTSD in the future.
- Privacy: All participant’s information will remain completely confidential.
For more information, click here to view the IMPACT-1 Study brochure, or visit impact1study.com.
Opening Times
- Monday08:00am to 06:30pm
Chatto Road only between 6pm and 6:30pm - Tuesday08:00am to 06:00pm
Chatto Road only between 6pm and 6:30pm - Wednesday08:00am to 06:30pm
Chatto Road only between 6pm and 6:30pm - Thursday08:00am to 06:30pm
Chatto Road only between 6pm and 6:30pm - Friday08:00am to 06:30pm
Chatto Road only between 6pm and 6:30pm - SaturdayCLOSED
- SundayCLOSED
Useful Links
